Sichuan Languang Development Co Ltd
SSE:600466
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/FCFF
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Valuation Scenarios
If EV/FCFF returns to its Industry Average (17.3), the stock would be worth ¥-0.88 (321% downside from current price).
| Scenario | EV/FCFF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -7.9 | ¥0.4 |
0%
|
| Industry Average | 17.3 | ¥-0.88 |
-321%
|
| Country Average | 28.8 | ¥-1.47 |
-467%
|
Forward EV/FCFF
Today’s price vs future free cash flow to firm
Peer Comparison
| Market Cap | EV/FCFF | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
|
Sichuan Languang Development Co Ltd
SSE:600466
|
1.2B CNY | -7.9 | -0 | |
| HK |
|
China Resources Land Ltd
HKEX:1109
|
231.8B HKD | 11.7 | 7.8 | |
| VN |
V
|
Vinhomes JSC
VN:VHM
|
599.7T VND | 26.4 | 14.3 | |
| HK |
|
CK Asset Holdings Ltd
HKEX:1113
|
171B HKD | 11.8 | 15.7 | |
| HK |
|
Henderson Land Development Co Ltd
HKEX:12
|
149B HKD | 34 | 26.4 | |
| HK |
|
China Overseas Land & Investment Ltd
HKEX:688
|
145.3B HKD | 5.2 | 10.2 | |
| HK |
|
Sino Land Co Ltd
HKEX:83
|
118.5B HKD | 26.2 | 31.7 | |
| CN |
|
China Merchants Shekou Industrial Zone Holdings Co Ltd
SZSE:001979
|
78.4B CNY | 42.8 | 76.6 | |
| CN |
|
Poly Developments and Holdings Group Co Ltd
SSE:600048
|
72.9B CNY | 14.2 | 1 402.9 | |
| IN |
|
Macrotech Developers Ltd
NSE:LODHA
|
911.7B INR | 121.6 | 26.7 | |
| CN |
|
Longfor Group Holdings Ltd
HKEX:960
|
56.5B HKD | 4.8 | 48.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 14.5 |
| Median | 28.8 |
| 70th Percentile | 57 |
| Max | 307 555.7 |
Other Multiples
Sichuan Languang Development Co Ltd
Glance View
Sichuan Languang Development Co., Ltd. engages in the development and operation of real estate. The company is headquartered in Chengdu, Sichuan and currently employs 2,791 full-time employees. The company went IPO on 2001-02-12. The Real Sstate Development & Operation segment has more than 100 development projects in nearly 20 cities in China. The Modern Service Industry segment provides property service based modern services through the subsidiary, Sichuan JUSTBON Asset Management Group Co., Ltd. The 3D Bio-printing segment is involved in the application of 3D bio-printing technology through the subsidiary, Sichuan Revotek Bio-technology Co., Ltd. The Medical segment is involved in the research and development, production and sales of medicine and medical instruments through the subsidiary, Chengdu Dikang Pharmaceutical Co., Ltd.
